Literature DB >> 17590137

[Tools to measure treatment adherence].

X Nogués Solán1, M L Sorli Redó, J Villar García.   

Abstract

Adherence measurement of treatments is necessary, in spite there are several tools the most of them do not achieve fully the goal. Adherence is a word that includes two concepts: compliance to doses and administration way and persistence on the treatment time. One of these tools is the pharmacy data base. It has been demonstrated using this tool that persistence for osteoporosis patient treatments could be fewer than 25% after one year of prescription. An extended tool is the count of not taked pills that inform of adherence percentage in a period of time. One very useful self- administrated questionnaire is the Morisky-Green with a Spanish version validated by Val Jimenez et al. This questionnaire consists of four simple and short questions. Recently it has been introduced electronic methods that permit to know when and what time the patient takes the pill. Measurement of adherence is not easy and it is necessary to use some tools at the same time to avoid overestimation. Diseases with a long period of treatment as osteoporosis the increase of adherence is needed to prevent fractures.

Entities:  

Mesh:

Year:  2007        PMID: 17590137     DOI: 10.4321/s0212-71992007000300009

Source DB:  PubMed          Journal:  An Med Interna        ISSN: 0212-7199


  6 in total

1.  [Treatment adherence and persistence: causes, consequences and improvement strategies].

Authors:  Tatiana Dilla; Amparo Valladares; Luis Lizán; José Antonio Sacristán
Journal:  Aten Primaria       Date:  2009-05-07       Impact factor: 1.137

2.  Dynamic complexity measures and entropy paths for modelling and comparison of evolution of patients with drug resistant epileptic encephalopathy syndromes (DREES).

Authors:  Ricardo Zavala-Yoe; Ricardo A Ramirez-Mendoza
Journal:  Metab Brain Dis       Date:  2017-06-09       Impact factor: 3.584

3.  EDUCORE project: a clinical trial, randomised by clusters, to assess the effect of a visual learning method on blood pressure control in the primary healthcare setting.

Authors:  Isidro Rodríguez-Salceda; Esperanza Escortell-Mayor; Milagros Rico-Blázquez; Rosario Riesgo-Fuertes; Angel Asúnsolo-del Barco; Antonio Valdivia-Pérez; Isabel del Cura-González; Ana B García-Cañón; María F Ortiz-Jiménez; Luisa Cabello-Ballesteros; Sofia Garrido-Elustondo; Laura Chamorro-González; Ricardo Rodríguez-Barrientos
Journal:  BMC Public Health       Date:  2010-07-30       Impact factor: 3.295

4.  Impact of treatment with direct-acting antivirals on anxiety and depression in chronic hepatitis C.

Authors:  Marta Gallach; Mercedes Vergara; Joao Pedro da Costa; Mireia Miquel; Meritxell Casas; Jordi Sanchez-Delgado; Blai Dalmau; Núria Rudi; Isabel Parra; Teresa Monllor; Meritxell Sanchez-Lloansí; Angelina Dosal; Oliver Valero; Xavier Calvet
Journal:  PLoS One       Date:  2018-12-19       Impact factor: 3.240

5.  [Evaluation of the FD-66 Scale as a tool for predicting treatment adherence in patients with chronic non-communicable diseasesAvaliação da escala EFD-66 como instrumento para predizer a adesão ao tratamento em pacientes com doenças crônicas não transmissíveis].

Authors:  Gabriela Anahí Pedroza Cosío; Laura Elena Sánchez Escobar; Silvia Munguía Lozano; Luis Beltrán Lagunes; José Guillermo Ferrer Álvarez; Rosana Medina Arreguín; Daniel López Hernández
Journal:  Rev Panam Salud Publica       Date:  2017-11-11

6.  A primary healthcare information intervention for communicating cardiovascular risk to patients with poorly controlled hypertension: The Education and Coronary Risk Evaluation (Educore) study-A pragmatic, cluster-randomized trial.

Authors:  Esperanza Escortell-Mayor; Isabel Del Cura-González; Elena Ojeda-Ruiz; Teresa Sanz-Cuesta; Isidro Rodríguez-Salceda; Jesús García-Soltero; María-José Rojas-Giraldo; Pedro Herrera-Municio; Alicia Jorge-Formariz; Ángela Lorenzo-Lobato; Luisa Cabello-Ballesteros; Rosario Riesgo-Fuertes; Sofía Garrido-Elustondo; Mariel Morey-Montalvo; Milagros Rico-Blázquez; Ricardo Rodríguez-Barrientos; María-Dolores Fuente-Arriaran; Gloria Sierra-Ocaña; Encarnación Serrano-Serrano; Carmelina Sanz-Velasco; Roberto Carrascoso-Calvo; Juan Carlos Recio-Velasco; Marta Sanz-Sanz; Mercedes Rumayor-Zarzuelo; Olga-Inés Bermejo-Mayoral; Josefina Galán-Esteban; Antonio Sarría-Santamera
Journal:  PLoS One       Date:  2020-01-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.